Data: 08/08/2026
Total encontrado: 7
1/7US=84 / Biol/Mol
Liu IM, Schilling SH, Wang XF. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: Cooperation between TGF-B and Wnt pathway components in regulating mesenchymal stem cell function. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 293-303. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3.

CELULAS-TRONCO MESENQUIMAIS; SMAD3; B-CATENINA; CROSSTALK; PROLIFERACAO; DIFERENCIACAO

2/7US=84-A / Biol/Mol
Ruscetti F, Akel S, Birchenall-Roberts M, Cao Z, Roberts AB. Transformig growth factor-B in developing and advanced cancers: smad signaling in leukemic growth and differentiation: crosstalk between smad and multiple pathways through activation of the TGF-B type I receptor. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 247-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FATOR TRANSFORMADOR DE CRESCIMENTO - B; LEUCEMIA; DIFERENCIACAO; CROSSTALK SMAD SINALIZACAO; MAPK SINALIZACAO TUBERINA

3/7US=90 / Biol/Mol
Gavard J, Gutkind JS. EGFR signaling networks: a molecular crosstalk between e-cadlherin and EGFR signaling networks. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 139-54. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGFR; JUNCOES CELULARES; ADESAO CELULAR; CADERINA; CATENINA MIGRACAO; ACTINA

4/7US=90 / Biol/Mol
Becker MA, Yee D. EGFR signaling networks: crosstalk between insulin-like growth factor (IGF) and epidermal growth factor (EGF) receptors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 155-68. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGFR; IGF-IR; CANCER; MSPK; PI3K; CROSSTALK

5/7US=90 / Biol/Mol
Dannenberg AJ, Subbaramaiah K. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: crosstalk between COX-2 and EGFR: apontential therapeutic opportunity. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 337-51. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

CICLOOXIGENASE-2; PROSTAGLANDINAS; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; CROSSTALK; CANCER

6/7US=47 / Clín/Medica
Migliaccio A, Castoria G, Di Domenico M, Ciociola A, Lombardi M, Falco A, Nanayakkara M, Bottero D, Stasio R, Varricchio L, Auricchio F. Crosstalk between EGFR and extranuclear steroid receptors. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 194-200. ISBN 978-1-57331-699-5.

DIAFONIA ENTRE O EGFR; RECEPTORES DE ESTEROIDES EXTRANUCLEARES; RECEPTOR DE ANDROGENO; RECEPTOR DE ESTROGENO; TRANSDUCAO DE SINAL; FATOR DE CRESCIMENTO EPIDERMICO

7/7US=752 / Tese/FAP
Malentacchi ERM. O uso da citologia líquida para avaliação da expressão gênica e proteica de marcadores da via WNT associados a tumores de ovário. [The use of liquid citology for the gene and protein expression of WNT markers associated with ovarian tumors]. São Paulo, 2019. 100 p. Tese(Doutorado)-Fundação Antonio Prudente.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2019/EMMalentacchi/EMMalentacchi.pdf

Curriculum Lattes

NEOPLASIAS OVARIANAS; VIA DE SINALIZACAO WNT; EXPRESSAO GENICA; HISTOCITOQUIMICA; BIOMARCADORES